Revisiting the CXCL13/CXCR5 axis in the tumor microenvironment in the era of single-cell omics: Implications for immunotherapy

• Published in: Cancer letters Vol. 605; p. 217278
• Main Authors: Gu, Xuanyu, Li, Dongyu, Wu, Peng, Zhang, Chaoqi, Cui, Xinyu, Shang, Dexin, Ma, Ruijie, Liu, Jingjing, Sun, Nan, He, Jie
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 28.11.2024
• Subjects: CXCL13; CXCR5; Immunotherapy; scRNA-seq; Tumor microenvironment; CXCR5; scRNA-seq; Tumor microenvironment; CXCL13; Immunotherapy
• ISSN: 0304-3835; 1872-7980; 1872-7980
• DOI: 10.1016/j.canlet.2024.217278

As one of the important members of the family of chemokines and their receptors, the CXCL13/CXCR5 axis is involved in follicle formation in normal lymphoid tissues and the establishment of somatic cavity immunity under physiological conditions, as well as being associated with a wide range of infectious, autoimmune, and tumoral diseases. Here in this review, we focus on its role in tumors. Traditional studies have found the axis to be both pro- and anti-tumorigenic, involving a variety of immune cells, including the tumor cells themselves and those in the tumor microenvironment (TME), and the prognostic significance of this axis is clinical context-dependent. With the development of techniques at the single-cell level, we were able to explain in detail the status of the CXCL13/CXCR5 axis in the TME based on real clinical samples and found that it involves a range of crucial intrinsic anti-tumor immune processes in the TME and is therefore important in tumor immunotherapy. We summarize the cellular subsets, physiological functions, and prognostic significance associated with this axis in the most promising immune checkpoint inhibitor (ICI) therapies of the day and summarize possible therapeutic ideas based on this axis. As with any TME study, the most important takeaway is that the complexity of the CXCL13/CXCR5 axis in TME suggests the importance of personalized therapy in tumor therapy. •CXCL13/CXCR5 plays important roles in physiological setting and tumorigenesis.•CXCL13/CXCR5-related cellular subtypes play vital roles in tumor progression and immunotherapeutic response.•Single-cell-based technologies provided new perspectives to traditional chemokine research.